Portfolio company
Paterna Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Paterna Biosciences develops in vitro spermatogenesis technology to produce functional sperm from stem cells for clinics treating male infertility.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
PATH FERTILITY
This company develops epigenetic sperm quality tests for men and clinicians to identify subfertility missed by standard semen analysis.
Vitra Bio
This biotechnology company develops in vitro fertilization technology and cell-based therapies to induce oogenesis outside the ovary for patients struggling with infertility.
Vitra Labs
The company develops a stem cell platform to produce eggs for patients undergoing fertility treatments without the use of hormones or donor tissue.
Dioseve
This biotechnology company develops induced pluripotent stem cell-derived oocytes and ovarian somatic cells to treat infertility patients who cannot produce viable eggs.
Gameto
This biotechnology company develops cell-based therapies and egg maturation protocols for fertility clinics and patients undergoing reproductive treatments.
CytoSwim
CytoSwim manufactures sperm selection devices for fertility clinics to isolate high-quality cells for use in assisted reproductive treatments like IVF.
FertereX
This company develops a photobiomodulation therapy device designed to improve sperm quality and testosterone levels for men experiencing fertility issues.
Plan A
This company develops long-lasting, non-hormonal and reversible male contraceptive products for the consumer health market.